Comparison of pulmonary arterial pressure in patients under chronic hemodialysis with and without arteriovenous fistula

Shahdak Dadashpour, Behzad Saeidi, Ghobad Moradi, Kazhal Karimi, Ahmad Fotoohi

DOI: 10.22122/cdj.v7i2.387


BACKGROUND: Pulmonary arterial hypertension (PAH) is a progressive disorder and a newly-discovered disease in people with end stage renal disease (ESRD). In patients who are hemodialyzed through arteriovenous fistula (AVF), the incidence of pulmonary hypertension (PHT) is highly probable. Regarding the main role of the AVF in the pathogenesis of PAH and the fact that AVF is the main method of vascular access in patients undergoing dialysis, we decided to investigate pulmonary artery pressure (PAP) in patients under chronic hemodialysis.

METHODS: This was a cross-sectional study. All patients with chronic hemodialysis were divided into two groups according to the status of the fistula. The number of cases examined included 100 patients and data were analyzed by SPSS software.

RESULTS: The most common cause of ESRD was hypertension (HTN) followed by diabetes mellitus (DM), polycystic kidney disease (PKD), urologic disorders, DM and HTN, combined blood pressure (BP) and PKD, renal stones, and other items ultimately. The average creatinine level was 8.59 mg/dl. Therefore, the mean creatinine level of patients, although relative to mode and median, was in any case significantly higher than the mean, which was predictable according to the ESRD community studied. The mean phosphate level was 5.66 mg/dl, and the mean hemoglobin (Hb) was 11.56 g/dl. The mean parathyroid hormone (PTH) and PAP were 558.68 and 27.33 mmHg, respectively, and the mean of ejection fraction (EF) was 50.75%. There was a significant difference between the mean PAP in the two groups (P = 0.048), as it was higher in the AVF group.

CONCLUSION: Results of this study showed that AVF and ESRD both were risk factors for high PAP and PHT.


Pulmonary Hypertension; End Stage Renal Disease; Arteriovenous Fistula

Full Text:



Martin KB, Klinger JR, Rounds SI. Pulmonary arterial hypertension: New insights and new hope. Respirology 2006; 11(1): 6-17.

Unal A, Tasdemir K, Oymak S, Duran M, Kocyigit I, Oguz F, et al. The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients. Hemodial Int 2010; 14(4): 398-402.

Acarturk G, Albayrak R, Melek M, Yuksel S, Uslan I, Atli H, et al. The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients. Int Urol Nephrol 2008; 40(2): 509-13.

Emara Magdy M, Habeb Mohamad A, Alnahal AA, Elshazly TA, Alatawi FO, Masoud AS. Prevalence of pulmonary hypertension in patients with chronic kidney disease on and without dialysis. Egypt J Chest Dis Tuberc 2013; 62(4): 761-8.

Mousavi SA, Mahdavi-Mazdeh M, Yahyazadeh H, Azadi M, Rahimzadeh N, Yoosefnejad H, et al. Pulmonary hypertension and predisposing factors in patients receiving hemodialysis. Iran J Kidney Dis 2008; 2(1): 29-33.

Mahdavi-Mazdeh M, Alijavad-Mousavi S, Yahyazadeh H, Azadi M, Yoosefnejad H, Ataiipoor Y. Pulmonary hypertension in hemodialysis patients. Saudi J Kidney Dis Transpl 2008; 19(2): 189.

Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 2008; 28(6): 990-7.

Dagli CE, Sayarlioglu H, Dogan E, Acar G, Demirpolat G, Ozer A, et al. Prevalence of and factors affecting pulmonary hypertension in hemodialysis patients. Respiration 2009; 78(4): 411-5.

Amin M, Fawzy A, Hamid MA, Elhendy A. Pulmonary hypertension in patients with chronic renal failure: Role of parathyroid hormone and pulmonary artery calcifications. Chest 2003; 124(6): 2093-7.

Janda S, Shahidi N, Gin K, Swiston J. Diagnostic accuracy of echocardiography for pulmonary hypertension: A systematic review and meta-analysis. Heart 2011; 97(8): 612-22.

Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration 2007; 74(5): 503-10.

Archer S, Rich S. Primary pulmonary hypertension: A vascular biology and translational research "Work in progress". Circulation 2000; 102(22): 2781-91.

Ahmed I, Pansota MS, Tariq M, Tabassam SA, Salim MS. Arterio-venous (AV) fistula: surgical outcome and primary failure rate. Journal of University Medical & Dental College 2012; 3(1): 27-32.

Vassalotti JA, Jennings WC, Beathard GA, Neumann M, Caponi S, Fox CH, et al. Fistula First Breakthrough Initiative: Targeting Catheter Last in Fistula First. Seminars in Dialysis 2012; 25(3): 303-10

Cronenwett JL, Johnston KW. Rutherford's vascular surgery. Philadelphia, PA: Elsevier Health Sciences; 2010.

Centre for Clinical Practice. National institute for health and clinical excellence [Online]. [cited 2011]; Available from: URL:

Bloembergen WE. Cardiac disease in chronic uremia: Epidemiology. Adv Ren Replace Ther 1997; 4(3): 185-93.

Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int 2006; 10(4): 356-9.

Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 2005; 20(8): 1686-92.

Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 2008; 86(10):


Fabbian F, Cantelli S, Molino C, Pala M, Longhini C, Portaluppi F. Pulmonary hypertension in dialysis patients: A cross-sectional Italian study. Int J Nephrol 2010; 2011: 283475.

Pabst S, Hammerstingl C, Hundt F, Gerhardt T, Grohe C, Nickenig G, et al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: Results of the PEPPER-study. PLoS One 2012; 7(4): e35310.

Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004; 351(16): 1655-65.

Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62(25 Suppl): D34-D41.

Hayati F, Beladi Mousavi SS, Mousavi Movahed SM, Mofrad Bushehri M. Pulmonary hypertension among patients undergoing hemodialysis. J Renal Inj Prev 2016; 6(2): 122-126.

Hemnes AR, Chittineni D, Astor BC, Hassoun PM, Atta MG. Pulmonary hypertension is prevalent in catheter and arterio-venous access hemodialysis. Nephrology Research & Reviews 2010; 2(1): 10-4.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 4.0

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.